What is Pancreatic Cancer?

whitePaper | June 7, 2022

In a recent webinar, Dawn Crump, Senior Director of Revenue Cycle Solutions at the Norristown, Pennsylvania-based MRO Corporation, shared her expertise with her virtual audience, around the very important topic of payment integrity audits.

whitePaper | December 3, 2022

In the past three decades, cloud computing as we now know it has undergone many changes. Long gone are the days where large corporations had a single off-site server parsing data. Today, businesses of all sizes are embracing the cloud for storage to services and beyond.

whitePaper | January 17, 2020

Value-based reimbursement (VBR) models are becoming more common. Success under these models depends on showing positive improvement in key metrics, but providers often struggle to accurately report the quality of care provided. A next-generation revenue cycle that combines clinically aware artificial intelligence (AI) with an unmatched foundation of evidence-based medical research and knowledge provides the transparency necessary to both accurately report care quality and directly influence the patient satisfaction quality metric. This paper reviews how a well-tuned revenue cycle can help hospitals succeed with value-based contracts, earning appropriate incentives and avoiding penalties.

whitePaper | January 21, 2023

As a consequence of widespread consolidation of buying power within integrated healthcare networks (IHNs), Pharma, Medical Device, and Biotech sales and marketing teams are facing information gaps that threaten their sales growth if left unaddressed.

whitePaper | June 7, 2021

In an increasingly digitized world, healthcare organizations are looking for solutions to enhance their understanding of the health issues patients are facing and allow them to both meet their patients virtually and significantly contribute to disease diagnosis, prevention, and treatment.

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).